nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Head-On Ordinal Comparison of the Composite Time Trade-Off and the Better-Than-Dead Method
|
Roudijk, Bram |
|
|
23 |
2 |
p. 236-241 |
artikel |
2 |
Author's Reply
|
Murphy, Aileen |
|
|
23 |
2 |
p. 275 |
artikel |
3 |
Clinical Effectiveness of Decision Support for Prescribing Opioids for Chronic Noncancer Pain: A Prospective Cohort Study
|
Price-Haywood, Eboni G. |
|
|
23 |
2 |
p. 157-163 |
artikel |
4 |
Comparison of Different Case-Crossover Variants in Handling Exposure-Time Trend or Persistent-User Bias: Using Dipeptidyl Peptidase-4 Inhibitors and the Risk of Heart Failure as an Example
|
Dong, Yaa-Hui |
|
|
23 |
2 |
p. 217-226 |
artikel |
5 |
Copyright/Subscription
|
|
|
|
23 |
2 |
p. v |
artikel |
6 |
Cost-Effectiveness Analysis of Baseline Testing for Resistance-Associated Polymorphisms to Optimize Treatment Outcome in Genotype 1 Noncirrhotic Treatment-Naïve Patients With Chronic Hepatitis C Virus
|
Fawsitt, Christopher G. |
|
|
23 |
2 |
p. 180-190 |
artikel |
7 |
Editorial Board
|
|
|
|
23 |
2 |
p. vi |
artikel |
8 |
Effects of Lean Healthcare on Patient Flow: A Systematic Review
|
Tlapa, Diego |
|
|
23 |
2 |
p. 260-273 |
artikel |
9 |
Evaluation of Efficacy Endpoints for a Phase IIb Study of a Respiratory Syncytial Virus Vaccine in Older Adults Using Patient-Reported Outcomes With Laboratory Confirmation
|
Yu, Jing |
|
|
23 |
2 |
p. 227-235 |
artikel |
10 |
Health-Related Quality of Life in Children With Low Language or Congenital Hearing Loss, as Measured by the PedsQL and Health Utility Index Mark 3
|
Le, Ha N.D. |
|
|
23 |
2 |
p. 164-170 |
artikel |
11 |
Optimal Design of Population-Level Financial Incentives of Influenza Vaccination for the Elderly
|
Yue, Mu |
|
|
23 |
2 |
p. 200-208 |
artikel |
12 |
Quebec Health-Related Quality-of-Life Population Norms Using the EQ-5D-5L: Decomposition by Sociodemographic Data and Health Problems
|
Poder, Thomas G. |
|
|
23 |
2 |
p. 251-259 |
artikel |
13 |
“Stick or Twist?” Negotiating Price and Data in an Era of Conditional Approval
|
Gladwell, Daniel |
|
|
23 |
2 |
p. 191-199 |
artikel |
14 |
Supporting the Development of Evidence-Informed Policy Options: An Economic Evaluation of Hypertension Management in Ghana
|
Gad, Mohamed |
|
|
23 |
2 |
p. 171-179 |
artikel |
15 |
Table of Contents
|
|
|
|
23 |
2 |
p. i-iv |
artikel |
16 |
To HTA or Not to HTA: Identifying the Factors Influencing the Rapid Review Outcome in Ireland
|
O’Donnell, Helen |
|
|
23 |
2 |
p. 274-275 |
artikel |
17 |
Trends and Factors Associated With Insurer Approval of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Prescriptions
|
Doshi, Jalpa A. |
|
|
23 |
2 |
p. 209-216 |
artikel |
18 |
Value-Based Pharmaceutical Contracts: Value for Whom?
|
Kannarkat, Joseph T. |
|
|
23 |
2 |
p. 154-156 |
artikel |
19 |
Value of Information Analysis for Research Decisions—An Introduction: Report 1 of the ISPOR Value of Information Analysis Emerging Good Practices Task Force
|
Fenwick, Elisabeth |
|
|
23 |
2 |
p. 139-150 |
artikel |
20 |
What Difference Does It Make? A Comparison of Health State Preferences Elicited From the General Population and From People With Multiple Sclerosis
|
Goodwin, Elizabeth |
|
|
23 |
2 |
p. 242-250 |
artikel |
21 |
Why Reinvent the Wheel? Use or Modification of Existing Clinical Outcome Assessment Tools in Medical Product Development
|
Papadopoulos, Elektra J. |
|
|
23 |
2 |
p. 151-153 |
artikel |